Viavi and Brocade Deliver Highly Scalable Subscriber Data

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Viavi and Brocade Deliver Highly Scalable Subscriber Data Analytics Solution for Mobile Operators

MILPITAS, CA and SAN JOSE, CA--(Marketwired - Jun 28, 2016) -   Viavi Solutions ( NASDAQ : VIAV ) and Brocade ( NASDAQ : BRCD ) today announced a joint solution that enables mobile operators to capture and analyze subscriber data to quickly resolve quality of experience (QoE) issues. An industry-first solution, Viavi's xSIGHT Targeted Subscriber Search (TSS) leverages the Brocade Packet Broker and Brocade Session Director to filter and deliver targeted subscriber traffic so only the data required to resolve customer experience problems is forwarded to xSIGHT TSS. In addition to significantly reducing resolution time for QoE issues, the solution enables mobile operators to open up opportunities for new value-added services.

Viavi and Brocade developed this highly scalable solution to dynamically optimize the visibility of mobile networks. The joint solution is in production at a U.S. Tier-1 mobile operator to help provide better QoE to their subscribers and enable new premium services.

As subscribers increase network usage through more diverse devices and applications, the conditions for optimal QoE become more complex and unpredictable. Mobile operators are trying to improve the subscriber experience by allocating network resources based on application-specific requirements. This approach requires rapid analysis of network performance and subscriber QoE. Gathering data in trace files for full seven-layer analysis can take hours for each subscriber via traditional assurance systems. This length of time makes proper analysis prohibitively difficult as the capture received may no longer be relevant.

The xSIGHT TSS and Brocade Packet Broker address this operational inefficiency by targeting specific subscribers -- for example, VIPs or corporate customers covered by SLAs -- and capturing correlated control and user plane traffic, at a scale applicable to a Tier-1 mobile network. By reducing the average time spent gathering end-to-end subscriber traces from several hours to minutes, xSIGHT TSS and the Brocade Packet Broker can save mobile carriers up to tens of thousands of labor hours per year.

xSIGHT is Viavi's customer experience assurance portfolio including an analytics platform fed by agents distributed throughout the network. The agents passively analyze traffic in real time, build network and application performance metrics and selectively store traffic for troubleshooting purposes. xSIGHT TSS is an agent which can be programmed to capture all control and user plane data for targeted subscribers defined by the service provider.

The Brocade Packet Broker helps to scale the capacity of the xSIGHT solution to thousands of dynamically targeted subscribers per TSS, with programmability of all dynamic rules and filters with less than 1 ms latency, a critical requirement for today's mobile provider networks.

"As mobile operators chart the course to 5G and re-architect their networks to software-based, virtualized, and open New IP architectures, their visibility and analytics infrastructure needs to follow suit," said Kevin Shatzkamer, chief technology officer of mobile networking, Brocade. "With solutions from Brocade and Viavi, mobile subscribers can rest assured that networks are monitored, key performance indicators are measured, and service level agreements are provided to meet their growing need for reliable mobile communications. This allows operators to efficiently manage the consumption of Internet and video services as well as Internet of Things and machine-to-machine (M2M) connections."

"Network traffic is pushing mobile service providers to the limits of technology and human capabilities, and they are seeking efficiency in order to maximize productivity of their resources," said Sameh Yamany, Chief Technology Officer, Viavi Solutions. "To stay ahead of the compounding challenges in front of the industry, an ecosystem approach becomes increasingly essential. We are delighted to collaborate with Brocade in this successful implementation with one of the world's largest carriers." 

About Brocade Brocade ( NASDAQ : BRCD ) networking solutions help the world's leading organizations turn their networks into platforms for business innovation. With solutions spanning public and private data centers to the network edge, Brocade is leading the industry in its transition to the New IP network infrastructures required for today's era of digital business. ( www.brocade.com )

About Viavi Solutions Viavi ( NASDAQ : VIAV ) software and hardware platforms and instruments deliver end-to-end visibility across physical, virtual and hybrid networks. Precise intelligence and actionable insight from across the network ecosystem optimizes the service experience for increased customer loyalty, greater profitability and quicker transitions to next-generation technologies. Viavi is also a leader in anti-counterfeiting solutions for currency authentication and high-value optical components and instruments for diverse government and commercial applications. Learn more at www.viavisolutions.com and follow us on Viavi Perspectives , LinkedIn , Twitter , YouTube and Facebook .

Brocade Media Contact: Liza S. Goldberg 408.333.0337 lgoldber@brocade.com Viavi Media Contact: Sonus PR Martin Smith +1 (415) 202-3103 viavi@sonuspr.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 363

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 387

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 544

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Bloomberg, HKEX Expand Offshore RMB Bond Indices

Updated Category News Views 109

A Move to Elevate Dim Sum Bonds If you're wondering what's cooking in the bond market arena, Bloomberg and HKEX just turned up the heat with a new family of RMB bond indices. These aren't just any run-of-the-mill indices; they're targeting the offshore RMB market, affectionately called the Dim Sum bond market. For those of us grizzled vets in the trading world, this is...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 305

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 161

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 411

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 174

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 277

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Breakthroughs in Lung Cancer Treatment with Reqorsa

Updated Category News Views 182

Innovative Advances in Lung Cancer Treatment The fight against lung cancer continues to evolve, showcasing promising advancements that bring new hope to patients. Genprex, Inc. is at the forefront of this battle with its revolutionary gene therapy known as Reqorsa. This cutting-edge treatment has been developed specifically to target KRAS mutation in non-small cell lung...

Continue Reading
EfTEN United Property Fund Reports October Earnings and NAV

Updated Category News Views 192

Insights into EfTEN United Property Fund's Recent Performance EfTEN United Property Fund demonstrated a net profit of 110 thousand euros for October, totaling 2.214 million euros for the first ten months of the year, marking a significant improvement from 724 thousand euros during the same period last year. This impressive financial outcome led to a distribution to...

Continue Reading
Cardiff Oncology Reports Encouraging Results in mCRC Trial

Updated Category News Views 236

Cardiff Oncology Reveals Promising Clinical Trial Results Cardiff Oncology, Inc. (Nasdaq: CRDF), a pioneering clinical-stage biotechnology company, has recently announced encouraging results from its ongoing CRDF-004 clinical trial. This randomized Phase 2 trial is investigating the effects of onvansertib in patients suffering from first-line RAS-mutated metastatic...

Continue Reading
Japan's Growing Casting Polyurethane Market and Its Future

Updated Category News Views 127

Japan's Casting Polyurethane Market: A Rising Force The Japan casting polyurethane market is on the verge of significant transformation, anticipated to elevate from a valuation of US$ 134.74 million to a remarkable US$ 248.24 million by 2033. This growth trajectory highlights a compelling compound annual growth rate (CAGR) of 7.08%, revealing the underlying strength...

Continue Reading
Hudson Technologies Faces Challenges Amid Downgrade by B.Riley

Updated Category News Views 353

B.Riley Downgrades Hudson Technologies Stock In a recent market statement, B.Riley has lowered its outlook on Hudson Technologies (NASDAQ: HDSN), shifting the stock rating from Buy to Neutral. This adjustment comes amidst new growth projections adjusted downwards from +16.6% to +8.5%. The modification in expectations has been linked to ongoing pressures on...

Continue Reading